AI Assistant
Blog
Pricing
Log In
Sign Up
The burden of SARS-CoV-2 in patients receiving chimeric antigen receptor T cell immunotherapy: everything to lose
Details
Cite
Export
Add to List
This content is not available in your region!
Continue researching
here.